We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VICI icon
151
VICI Properties
VICI
$25.2B
$2.68M 0.08%
93,500
+16,850
+22% +$484K
2023 Q1
5 quarters
WDC icon
152
Western Digital
WDC
$149B
$2.65M 0.07%
+46,305
New +$2.57M
2024 Q2
0 quarters
JNJ icon
153
Johnson & Johnson
JNJ
$630B
$2.63M 0.07%
+18,000
New +$2.68M
2024 Q2
0 quarters
ZTO icon
154
ZTO Express
ZTO
$15.1B
$2.62M 0.07%
126,151
-56,801
-31% -$1.24M
2021 Q2
12 quarters
WOLF icon
155
Wolfspeed
WOLF
$1.62B
$2.62M 0.07%
115,000
+50,000
+77% +$1.29M
2024 Q1
1 quarter
ACEL icon
156
Accel Entertainment
ACEL
$893M
$2.61M 0.07%
254,737
– –
2020 Q1
17 quarters
CEG icon
157
Constellation Energy
CEG
$106B
$2.61M 0.07%
+13,030
New +$2.66M
2024 Q2
0 quarters
VST icon
158
Vistra
VST
$54.2B
$2.58M 0.07%
30,000
-10,000
-25% -$837K
2024 Q1
1 quarter
NETD icon
159
DELISTED
Nabors Energy Transition Corp II
NETD
$2.54M 0.07%
241,468
– –
2023 Q3
3 quarters
VAC icon
160
Marriott Vacations Worldwide
VAC
$3.62B
$2.54M 0.07%
29,100
-11,700
-29% -$1.11M
2024 Q1
1 quarter
MNTN icon
161
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$2.46M 0.07%
218,844
– –
2022 Q1
9 quarters
AIV icon
162
Aimco
AIV
$257M
$2.37M 0.07%
285,575
+92,375
+48% +$745K
2023 Q4
2 quarters
PTGX icon
163
Protagonist Therapeutics
PTGX
$9.3B
$2.36M 0.07%
68,231
-41,099
-38% -$1.2M
2022 Q1
9 quarters
SNDX icon
164
Syndax Pharmaceuticals
SNDX
$1.52B
$2.27M 0.06%
110,454
+2,023
+2% +$42.3K
2023 Q4
2 quarters
ABBV icon
165
AbbVie
ABBV
$489B
$2.26M 0.06%
13,195
+12,057
+1,059% +$2M
2022 Q3
7 quarters
NBIX icon
166
Neurocrine Biosciences
NBIX
$14.5B
$2.24M 0.06%
16,300
+2,300
+16% +$315K
2022 Q1
9 quarters
AEO icon
167
American Eagle Outfitters
AEO
$3.04B
$2.2M 0.06%
+110,000
New +$2.51M
2024 Q2
0 quarters
USAR icon
168
USA Rare Earth Inc
USAR
$4.71B
$2.19M 0.06%
206,973
– –
2023 Q3
3 quarters
ADC icon
169
Agree Realty
ADC
$8.2B
$2.18M 0.06%
35,163
+30,763
+699% +$1.82M
2019 Q4
18 quarters
APXI icon
170
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$2.18M 0.06%
187,581
– –
2022 Q1
9 quarters
MAA icon
171
Mid-America Apartment Communities
MAA
$13.6B
$2.17M 0.06%
15,189
+3,014
+25% +$403K
2022 Q2
8 quarters
MSTR icon
172
Strategy Inc
MSTR
$61.5B
$2.16M 0.06%
+15,670
New +$2.26M
2024 Q2
0 quarters
HTZ icon
173
PUT
Hertz
HTZ
$684M
$2.15M 0.06%
934,600
+752,700
+414% +$3.83M
2024 Q1
1 quarter
KNSA icon
174
Kiniksa Pharmaceuticals
KNSA
$6.22B
$2.13M 0.06%
113,995
+19,500
+21% +$365K
2022 Q3
7 quarters
IDYA icon
175
IDEAYA Biosciences
IDYA
$3.48B
$2.11M 0.06%
60,050
+8,005
+15% +$317K
2022 Q3
7 quarters

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.